Search - tctmd.com

Displaying 641 - 660 of 879

Sort: Relevancy | Date

Presentation TCT 2014

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

Presenter: Gregg W. Stone, Pieter C. Smits, Fernando Alfonso

September 14, 2014

News Conference News TCT 2014

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

September 14, 2014

News Conference News TCT 2014

Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent

September 14, 2014

News Conference News TCT 2014

PERFECT-LUTS: Endovascular Revascularization Shows Promise for Patients with ED, Lower Urinary Tract Symptoms

Yael L. Maxwell

September 14, 2014

News Conference News TCT 2014

OCT STEMI: Imaging-Guided PCI Shows Promise

September 14, 2014

News Conference News TCT 2014

CTO-IVUS Trial Supports IVUS Guidance for CTO PCI

September 14, 2014

News Conference News TCT 2014

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

Presentation TCT 2014

Multilayer Stents for the Treatment of Visceral Aneurysms: Hope or Hoax?

Presenter: John R. Laird Jr, Daniel J. McCormick, Dmitriy N. Feldman, Michel Camille Henry

September 13, 2014

Presentation TCT 2014

Covered Stents for Iliac and SFA Obstructive Disease: Overhyped or Underused?

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon

September 13, 2014

Presentation TCT 2014

Next-Generation Carotid Artery Stents: Are Mesh/Membrane Stents Game Changers?

Presenter: Leo Nelson Hopkins, Sriram S. Iyer, Zvonimir Krajcer, Peter A. Schneider

September 13, 2014

Presentation TCT 2014

Bare Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes

Presenter: Emmanouil S. Brilakis, J. Dawn Abbott

September 13, 2014

News Conference News TCT 2014

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

September 13, 2014

News Conference News TCT 2014

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

September 13, 2014

News Conference News TCT 2014

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

September 13, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

News Conference News TCT 2014

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

September 13, 2014

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

Presentation TCT 2013

Self-Expanding Stents Provide a Real Benefit During STEMI Intervention!

Presenter: Gilles Montalescot

October 31, 2013

Presentation TCT 2013

Mesh-Covered Stents Are Optimal Management Strategy for Thrombus!

Presenter: Dariusz Dudek

October 31, 2013

Advertisement

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent

PERFECT-LUTS: Endovascular Revascularization Shows Promise for Patients with ED, Lower Urinary Tract Symptoms

OCT STEMI: Imaging-Guided PCI Shows Promise

CTO-IVUS Trial Supports IVUS Guidance for CTO PCI

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Multilayer Stents for the Treatment of Visceral Aneurysms: Hope or Hoax?

Covered Stents for Iliac and SFA Obstructive Disease: Overhyped or Underused?

Next-Generation Carotid Artery Stents: Are Mesh/Membrane Stents Game Changers?

Bare Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

COMPARE II: BES, EES Show Similar Outcomes at Three Years

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

Self-Expanding Stents Provide a Real Benefit During STEMI Intervention!

Mesh-Covered Stents Are Optimal Management Strategy for Thrombus!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content